Today, the FDA issued draft guidance outlining a new regulatory pathway intended to help sponsors gain approval for highly ...
The Food and Drug Administration (FDA) announced a new proposal Monday for flexible drug approval pathway treatments ...
After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...
FDA unveils pathway ultra-rare disease therapies to approve gene-editing and RNA treatments when trials are unfeasible for small populations.
GlobalData on MSN
FDA to allow one pivotal trial instead of two for drug approval
Prasad and Makary disagree that some may believe this move shows the FDA relaxing its standards.
FDA's accelerated pathway allows new drugs to enter the market based on interim measures rather than waiting for long-term results like overall survival. Pharmaceutical companies are required to run ...
The FDA granted full approval encorafenib (Braftovi) in combination with cetuximab (Erbitux) and fluorouracil-based ...
Compass Pathways announced that its investigational psilocybin treatment has successfully met its primary endpoint in a Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results